Argus Research analyst Kristina Ruggeri upgrades Nordstrom (NYSE:JWN) from Hold to Buy.
Atlantic Equities Maintains Neutral on Biogen, Raises Price Target to $295
Atlantic Equities analyst Steve Chesney maintains Biogen (NASDAQ:BIIB) with a Neutral and raises the price target from $220 to $295.